We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.57%
This Fund
S&P 500
This Quarter
Est. Return
+13.37%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
–
AUM
$67.4B
AUM Growth
+$7.41B
(+12%)
Cap. Flow
+$633M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
30.51%
Holding
1,260
New
116
Increased
460
Reduced
490
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$905M |
| 2 |
AbbVie
ABBV
|
+$681M |
| 3 |
Broadcom
AVGO
|
+$666M |
| 4 |
Apple
AAPL
|
+$629M |
| 5 |
Eli Lilly
LLY
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.35B |
| 2 |
Tesla
TSLA
|
+$1.5B |
| 3 |
Microsoft
MSFT
|
+$889M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$832M |
| 5 |
Meta Platforms (Facebook)
META
|
+$770M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.89% |
| 2 | Consumer Discretionary | 13.98% |
| 3 | Healthcare | 11.36% |
| 4 | Communication Services | 7.54% |
| 5 | Financials | 6.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Ovid Therapeutics
OVID
$491M
| $144K | ﹤0.01% |
435,620
-125,210
| -22% | -$37.7K |
|
1127
TripAdvisor
TRIP
$1.26B
| $144K | ﹤0.01% |
11,007
-595,000
| -98% | -$7.95M |
|
1128
Titan International
TWI
$475M
| $140K | ﹤0.01% |
13,622
| – | – |
|
|
NIU
1129
Niu Technologies
NIU
$193M
| $137K | ﹤0.01% |
40,865
-100,871
| -71% | -$347K |
|
1130
Commercial Vehicle Group
CVGI
$147M
| $137K | ﹤0.01% |
82,569
+45,944
| +125% | +$55.9K |
|
1131
Digital Turbine
APPS
$1.74B
| $135K | ﹤0.01% |
22,933
-7,383
| -24% | -$30.3K |
|
1132
Arbutus Biopharma
ABUS
$915M
| $122K | ﹤0.01% |
+39,610
| New | +$132K |
|
1133
Alphatec Holdings
ATEC
$1.44B
| $116K | ﹤0.01% |
10,447
| – | – |
|
1134
Forrester Research
FORR
$224M
| $109K | ﹤0.01% |
11,019
| – | – |
|
1135
DHI Group
DHX
$173M
| $108K | ﹤0.01% |
36,475
| – | – |
|
|
CLSD
1136
DELISTED
Clearside Biomedical
CLSD
| $106K | ﹤0.01% |
8,794
| – | – |
|
1137
Design Therapeutics
DSGN
$876M
| $105K | ﹤0.01% |
31,125
-5,792
| -16% | -$21.7K |
|
|
DENN
1138
DELISTED
Denny's
DENN
| $103K | ﹤0.01% |
25,147
| – | – |
|
1139
Iovance Biotherapeutics
IOVA
$2.87B
| $80.6K | ﹤0.01% |
46,842
| – | – |
|
1140
Cullinan Oncology
CGEM
$1.14B
| $75.8K | ﹤0.01% |
10,062
| – | – |
|
1141
GoPro
GPRO
$126M
| $71.3K | ﹤0.01% |
94,166
-203,280
| -68% | -$132K |
|
|
OPTU
1142
Optimum Communications Inc
OPTU
$301M
| $59.5K | ﹤0.01% |
27,791
| – | – |
|
1143
Neuronetics
STIM
$166M
| $48K | ﹤0.01% |
13,761
-83,895
| -86% | -$331K |
|
1144
AXT Inc
AXTI
$5.8B
| $42.7K | ﹤0.01% |
20,412
| – | – |
|
1145
Nuvation Bio
NUVB
$2.32B
| $35.5K | ﹤0.01% |
18,209
-5,806
| -24% | -$12.1K |
|
1146
Vera Bradley
VRA
$98.7M
| $32.8K | ﹤0.01% |
14,859
-4,986
| -25% | -$10.3K |
|
1147
Noodles & Co
NDLS
$107M
| $17.9K | ﹤0.01% |
3,140
| – | – |
|
1148
Harvard Bioscience
HBIO
$29.2M
| $16.3K | ﹤0.01% |
3,680
-1,763
| -32% | -$7.37K |
|
1149
Applied Optoelectronics
AAOI
$11.5B
| – | – |
-976,520
| Closed | -$15M |
|
1150
Ambev
ABEV
$46.4B
| – | – |
-27,415
| Closed | -$63.9K |
|
Similar funds
Assenagon Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Assenagon Asset Management held 1,260 positions worth $67.4B, up 12% from $59.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Assenagon Asset Management's Q2 2025 filing shows 116 new, 460 increased, 490 reduced and 112 closed positions. Its largest new stake was Alibaba: 2,006,591 shares worth $228M. The largest sale was NVIDIA, an estimated $2.35B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Assenagon Asset Management's largest Q2 2025 buy was Alibaba: 2,006,591 shares worth $228M.
- Assenagon Asset Management added most to Adobe in Q2 2025, an estimated $905M increase.
- Assenagon Asset Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $2.35B.
- Assenagon Asset Management fully exited The AZEK Co in Q2 2025, selling an estimated $54.6M.
- Assenagon Asset Management's ten largest holdings make up 31% of its $67.4B portfolio in Q2 2025.
- Assenagon Asset Management opened 116 new positions and closed 112 in Q2 2025.
- Assenagon Asset Management's portfolio value rose 12% quarter-over-quarter to $67.4B.
Based on Assenagon Asset Management's 13F filing for Q2 2025, filed 11 Jul 2025.